Phase 3 trials for three different agents show substantial reductions in kidney function decline and other improvements ...

A benign biopsy result can be reassuring — but it only reflects the tissue sampled. Learn why clinical context is essential before closing the case.

Listener feedback on the nonobstructive HCM trials, AI-enhanced visits, timing of non-culprit PCI in STEMI, new tricuspid ...

Patients report waiting a mean of 14 years for an IL-1-mediated autoinflammatory diagnosis. What to recognize, when to test, and how to use IL-1 blockade.

Upadacitinib, a JAK1 inhibitor, is linked to a lower risk for treatment failure and more steroid-free disease stability than ...

Everyday medical equipment is shedding micro- and nanoplastics into patients, bypassing their bodies’ natural filters and ...

Energy drink use in adolescents may be a marker of sleep debt, and clinicians should treat it as a cue to screen for short ...

A pooled phase 3 analysis shows that 15-mg and 20-mg doses of estetrol both reduce the frequency and severity of ...

Synthesizing medical management strategies with surgical and interventional treatments improves outcomes in patients with ...

Adults in late midlife who volunteer show a lower prevalence of high blood pressure than those who do not, regardless of ...

Diabetic peripheral neuropathy is among the most common and debilitating complications of type 2 diabetes, but early ...

Higher baseline B-cell counts and IL-6 concentrations are associated with an increased risk for cytokine release syndrome ...